Omnipod 5 DEXG7G6 pods (GEN 5) 5S

Ended Awarded Last action

Contract number
SPE2DR26FXSA1
Awardee
Awarding agency
Obligated
$14,648

Award facts

Contract value 100% obligated
$14,647.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $14,647.80 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods to be delivered to Conshohocken, Pennsylvania, with a completion date of December 31, 2025. This non-competitive, firm fixed-price delivery order was awarded on December 30, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX vehicle functions as a comprehensive global pharmaceutical and medical supply support mechanism enabling AmerisourceBergen to supply critical medical commodities, including specialty medications, vaccines, and medical devices, to support military healthcare programs and other federal healthcare systems worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting portfolio with DLA, primarily focused on pharmaceutical and medical device procurement. The company's federal contract awards demonstrate consistent capability in fulfilling diverse medical supply needs through open competition, with transaction values ranging substantially from under $100 to over $45,000. This award of insulin pump pods aligns with AmerisourceBergen's established role as a critical vendor for the Defense Health Agency and military healthcare systems, supporting diabetes management and other specialized therapeutic requirements across the federal medical supply chain.

Quick answers

Who was awarded contract SPE2DR26FXSA1?

SPE2DR26FXSA1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.

How much is contract SPE2DR26FXSA1 worth?

The government has obligated $14,648 on SPE2DR26FXSA1.

Is contract SPE2DR26FXSA1 an order under another contract?

Yes. SPE2DR26FXSA1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.

Was contract SPE2DR26FXSA1 competed?

The extent of competition for SPE2DR26FXSA1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award